1. Home
  2. HQI vs KRRO Comparison

HQI vs KRRO Comparison

Compare HQI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

SELL

Current Price

$17.73

Market Cap

232.1M

ML Signal

SELL

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$16.62

Market Cap

204.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQI
KRRO
Founded
2002
2014
Country
United States
United States
Employees
75000
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.1M
204.1M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
HQI
KRRO
Price
$17.73
$16.62
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$19.00
★ $20.20
AVG Volume (30 Days)
25.4K
★ 208.1K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
★ 1.44%
N/A
EPS Growth
★ 73.08
N/A
EPS
★ 0.31
N/A
Revenue
★ $30,640,000.00
$6,392,000.00
Revenue This Year
$0.54
N/A
Revenue Next Year
$5.47
$56.67
P/E Ratio
$53.68
★ N/A
Revenue Growth
N/A
★ 181.46
52 Week Low
$7.38
$5.20
52 Week High
$20.84
$36.79

Technical Indicators

Market Signals
Indicator
HQI
KRRO
Relative Strength Index (RSI) 45.91 77.38
Support Level $15.28 $9.43
Resistance Level $18.49 N/A
Average True Range (ATR) 0.98 1.22
MACD -0.09 0.69
Stochastic Oscillator 34.17 83.40

Price Performance

Historical Comparison
HQI
KRRO

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: